Clinical significance of the HLA-E and CD94/NKG2 interaction

Archivum Immunologiae et Therapiae Experimentalis

Volumn 59, Issue 5, 2011, Pages 353-367

  Iwaszko, Milena ^a   Bogunia Kubik, Katarzyna ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

CD94 NKG2 receptor; HLA E; Pregnancy; Transplantation of hematopoietic stem cells; Viral infections

Indexed keywords

CD94 ANTIGEN; HLA E ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN BINDING; ANTIGEN FUNCTION; CD94 GENE; CHROMOSOME 12; CYTOTOXIC T LYMPHOCYTE; GENE CLUSTER; GENE EXPRESSION; GENETIC ORGANIZATION; GENETIC POLYMORPHISM; HISTOCOMPATIBILITY COMPLEX; HISTOCOMPATIBILITY GENE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL SYNAPSE; MOLECULAR INTERACTION; NATURAL KILLER CELL; NKG2 GENE; NONHUMAN; PREGNANCY; RECEPTOR AFFINITY; REVIEW; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; CYTOMEGALOVIRUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; POLYMORPHISM, GENETIC; PREGNANCY; PROTEIN BINDING;

EID: 80054094832     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-011-0137-y     Document Type: Review

References (85)

1. AA Ashkar GP Black Q Wei, et al. 2003 Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy J Immunol 171 2937 2944 12960317 1:CAS:528: DC%2BD3sXmvFGqtL4%3D (Pubitemid 37093515)
2. A Barakonyi KT Kovacs E Miko, et al. 2002 Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy J Immunol 168 2683 2688 11884433 1:CAS:528:DC%2BD38XitFSktr0%3D (Pubitemid 34211644)
3. S Bauer V Groh J Wu, et al. 1999 Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 285 727 729 10426993 10.1126/science.285.5428.727 1:CAS:528:DyaK1MXltVehsro%3D (Pubitemid 29484539)
4. M Bianchini E Levy C Zucchini, et al. 2006 Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa Int J Oncol 29 83 94 16773188 1:CAS:528:DC%2BD28XntlWrsbo%3D
5. FA Bland MK Lemberg AJ McMichael, et al. 2003 Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E J Biol Chem 278 33747 33752 12821659 10.1074/jbc.M305593200 1:CAS:528:DC%2BD3sXmvVCrt7c%3D (Pubitemid 37553208)
6. K Bogunia-Kubik E Jaskuła M Polak, et al. 2010 Non classical HLA-E and G gene polymorphisms affect the HSCT outcome Bone Marrow Transplant 45 suppl 2 S135 (abstract P533)
7. K Bogunia-Kubik M Polak K Kościńska, et al. 2009 Chromosome 6 gene polymorphisms as the factors affecting the risk of HSCT outcome Eur J Immunol 39 suppl 1 S734 (abstract PD12/10)
8. F Borrego J Kabat DK Kim, et al. 2002 Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells Mol Immunol 38 637 660 11858820 10.1016/S0161-5890(01) 00107-9 1:CAS:528:DC%2BD38XhtlSntbs%3D (Pubitemid 34168194)
9. F Borrego M Masilamani AI Marusina, et al. 2006 The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance Immunol Res 35 263 278 17172651 10.1385/IR:35:3:263 1:CAS:528:DC%2BD28Xht1OjsbbN (Pubitemid 46020727)
10. F Borrego M Ulbrecht EH Weiss, et al. 1998 Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis J Exp Med 187 813 818 9480992 10.1084/jem.187.5.813 1:CAS:528:DyaK1cXhs1anurg%3D (Pubitemid 28115198)
11. JC Boyington AN Riaz A Patamawenu, et al. 1999 Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors Immunity 10 75 82 10023772 10.1016/S1074-7613(00)80008-4 1:CAS:528:DyaK1MXhtFarsb4%3D (Pubitemid 29077385)
12. V Braud EY Jones A McMichael 1997 The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9 Eur J Immunol 27 1164 1169 9174606 10.1002/eji.1830270517 1:CAS:528:DyaK2sXjtlagsL4%3D (Pubitemid 27197219)
13. VM Braud DS Allan CA O'Callaghan, et al. 1998 HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C Nature 391 795 799 9486650 10.1038/35869 1:CAS:528:DyaK1cXhtlCjtbo%3D (Pubitemid 28099678)
14. VM Braud DS Allan D Wilson, et al. 1998 TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide Curr Biol 8 1 10 9427624 10.1016/S0960-9822(98)70014-4 1:CAS:528: DyaK1cXlt1KmsA%3D%3D (Pubitemid 28056248)
15. AG Brooks F Borrego PE Posch, et al. 1999 Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells J Immunol 162 305 313 9886400 1:CAS:528:DyaK1MXjt1OntQ%3D%3D (Pubitemid 29018934)
16. GB Cohen RT Gandhi DM Davis, et al. 1999 The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells Immunity 10 661 671 10403641 10.1016/S1074-7613(00)80065-5 1:CAS:528:DyaK1MXksVSmsLk%3D (Pubitemid 29302919)
17. MA Cooper TA Fehniger SC Turner, et al. 2001 Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset Blood 97 3146 3151 11342442 10.1182/blood.V97.10.3146 1:CAS:528:DC%2BD3MXjsl2ru74%3D
18. M Danzer H Polin J Pröll, et al. 2009 Clinical significance of HLA-E 0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation Transplantation 88 528 532 19696636 10.1097/TP.0b013e3181b0e79e 1:CAS:528:DC%2BD1MXhtVWrs7fL
19. EM de Kruijf A Sajet JGH van Nes, et al. 2010 HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients J Immunol 185 7452 7459 21057081 10.4049/jimmunol.1002629
20. L Derré M Corvaisier B Charreau, et al. 2006 Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells J Immunol 177 3100 3107 16920947 (Pubitemid 44277827)
21. JL Espinoza A Takami M Onizuka, et al. 2009 NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies Haematologica 94 1427 1434 19794085 10.3324/haematol.2009.008318 1:CAS:528:DC%2BD1MXhsVCrsrbL
22. H Furue K Matsuo H Kumimoto, et al. 2008 Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese Carcinogenesis 29 316 320 18174257 10.1093/carcin/bgm260 1:CAS:528: DC%2BD1cXislKhsb8%3D (Pubitemid 351359670)
23. P García M Llano AB de Heredia, et al. 2002 Human T cell receptor-mediated recognition of HLA-E Eur J Immunol 32 936 944 11920559 10.1002/1521-4141(200204)32:4<936::AID-IMMU936>3.0.CO;2-M (Pubitemid 34428808)
24. J Glienke Y Sobanov C Brostjan, et al. 1998 The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex Immunogenetics 48 163 173 9683661 10.1007/s002510050420 1:CAS:528: DyaK1cXls1ait7c%3D (Pubitemid 28352182)
25. MAG Gonçalves ML Discorde RT Simões, et al. 2008 Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer Eur J Obstet Gynecol Reprod Biol 141 70 74 18692948 10.1016/j.ejogrb.2008.06.010
26. C Grimsley A Kawasaki C Gassner, et al. 2002 Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data Tissue Antigens 60 206 212 12445303 10.1034/j.1399-0039.2002.600302. x 1:CAS:528:DC%2BD38Xps1Kltb4%3D (Pubitemid 35398823)
27. AS Heinzel JE Grotzke RA Lines, et al. 2002 HLA-E-dependent presentation of Mtb-derived antigen to human CD8 + T cells J Exp Med 196 1473 1481 12461082 10.1084/jem.20020609 1:CAS:528:DC%2BD38XpsVahtLo%3D (Pubitemid 35424941)
28. K Hikami N Tsuchiya T Yabe, et al. 2003 Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population Genes Immun 4 160 167 12618865 10.1038/sj.gene.6363940 1:CAS:528:DC%2BD3sXivVyqtbc%3D (Pubitemid 38967591)
29. N Hirankarn I Kimkong A Mutirangura 2004 HLA-E polymorphism in patients with nasopharyngeal carcinoma Tissue Antigens 64 588 592 15496202 10.1111/j.1399-0039.2004.00311.x 1:CAS:528:DC%2BD2cXhtVKjsrbK (Pubitemid 39472924)
30. AD Hodgkinson BA Millward AG Demaine 2000 The HLA-E locus is associated with age at onset and susceptibility to type 1 diabetes mellitus Hum Immunol 61 290 295 10689118 10.1016/S0198-8859(99)00116-0 1:CAS:528:DC%2BD3cXht1KqtLY%3D (Pubitemid 30117796)
31. A Ishitani N Sageshima N Lee, et al. 2003 Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition J Immunol 171 1376 1384 12874228 1:CAS:528:DC%2BD3sXlsFylsbc%3D (Pubitemid 36900070)
32. G Kabalak RM Thomas J Martin, et al. 2010 Association of an NKG2D gene variant with systemic lupus erythematosus in two populations Hum Immunol 71 74 78 19735685 10.1016/j.humimm.2009.09.352 1:CAS:528:DC%2BD1MXhsFGgsb3O
33. BK Kaiser F Barahmand-Pour W Paulsene, et al. 2005 Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics J Immunol 174 2878 2884 15728498 1:CAS:528:DC%2BD2MXhsFeqsb8%3D (Pubitemid 40279705)
34. L Kren O Slaby K Muckova, et al. 2010 Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance? Neuropathology 31 129 134 10.1111/j.1440-1789.2010. 01149.x
35. J Lajoie J Hargrove LS Zijenah, et al. 2006 Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1 J Infect Dis 193 298 301 16362895 10.1086/498877 1:CAS:528:DC%2BD28XhtVynsrw%3D (Pubitemid 43113493)
36. LL Lanier B Corliss J Wu, et al. 1998 Association of DAP12 with activating CD94/NKG2C NK cell receptors Immunity 8 693 701 9655483 10.1016/S1074-7613(00)80574-9 1:CAS:528:DyaK1cXktFOmsLc%3D (Pubitemid 28294516)
37. N Lee DR Goodlett A Ishitani, et al. 1998 HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences J Immunol 160 4951 4960 9590243 1:CAS:528:DyaK1cXjtVanurk%3D (Pubitemid 28215330)
38. N Lee M Llano M Carretero, et al. 1998 HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A Proc Natl Acad Sci USA 95 5199 5204 9560253 10.1073/pnas.95.9.5199 1:CAS:528:DyaK1cXivV2jtrs%3D (Pubitemid 28208575)
39. MK Lemberg FA Bland A Weihofen, et al. 2001 Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes J Immunol 167 6441 6446 11714810 1:CAS:528:DC%2BD3MXovVCitrk%3D (Pubitemid 33081577)
40. RH Lian M Maeda S Lohwasser, et al. 2002 Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro J Immunol 168 4980 4987 11994449 1:CAS:528: DC%2BD38XjslSjsbc%3D (Pubitemid 34495960)
41. LD Lieto F Borrego C-H You, et al. 2003 Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15 J Immunol 171 5277 5286 14607929 1:CAS:528:DC%2BD3sXoslyisLo%3D (Pubitemid 37432813)
42. LD Lieto K Maasho D West, et al. 2006 The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B Genes Immun 7 36 43 16237464 10.1038/sj.gene.6364268 1:CAS:528:DC%2BD28XntFSktg%3D%3D
43. A Lin H Xu W Yan 2007 Modulation of HLA expression in human cytomegalovirus immune evasion Cell Mol Immunol 4 91 98 17484802
44. Y-J Lin L Wan J-Y Wu, et al. 2009 HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms Arthritis Rheum 60 604 610 19180512 10.1002/art.24261 1:CAS:528: DC%2BD1MXjt1Cnsrc%3D
45. M Llano M Gumá M Ortega, et al. 2003 Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets Eur J Immunol 33 2744 2754 14515258 10.1002/eji.200324182 1:CAS:528:DC%2BD3sXosFSjsbg%3D (Pubitemid 37337140)
46. M López-Botet T Bellón 1999 Natural killer cell activation and inhibition by receptors for MHC class I Curr Opin Immunol 11 301 307 10375552 10.1016/S0952-7915(99)80048-X (Pubitemid 29263958)
47. K Ludajic A Rosenmayr I Faé, et al. 2009 Association of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation with unrelated donors Transplantation 88 1227 1228 19935378 10.1097/TP. 0b013e3181bbb8fe
48. KJ Malmberg V Levitsky H Norell, et al. 2002 IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism J Clin Invest 110 1515 1523 12438449 1:CAS:528:DC%2BD38XovFOmsro%3D (Pubitemid 35396922)
49. R Marín F Ruiz-Cabello S Pedrinaci, et al. 2003 Analysis of HLA-E expression in human tumors Immunogenetics 54 767 775 12618909 (Pubitemid 36384471)
50. J Michaëlsson CT de Matos A Achour, et al. 2002 A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition J Exp Med 196 1403 1414 12461076 10.1084/jem.20020797 (Pubitemid 35424935)
51. MC Mingari G Pietra L Moretta 2005 Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors Curr Opin Immunol 17 312 319 15886123 10.1016/j.coi.2005.03.006 1:CAS:528:DC%2BD2MXjvFeksb4%3D (Pubitemid 40692668)
52. A Moretta L Moretta 1997 HLA class I specific inhibitory receptors Curr Opin Immunol 9 694 701 9368779 10.1016/S0952-7915(97)80051-9 1:CAS:528:DyaK2sXnt12gsrY%3D (Pubitemid 27485299)
53. J Nattermann HD Nischalke V Hofmeister, et al. 2005 The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells Am J Pathol 166 443 453 15681828 10.1016/S0002-9440(10)62267-5 1:CAS:528:DC%2BD2MXitVGnu7o%3D (Pubitemid 40189041)
54. J Nattermann HD Nischalke V Hofmeister, et al. 2005 HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells Antivir Ther 10 95 107 15751767 1:CAS:528:DC%2BD2MXis1Kmtbw%3D (Pubitemid 40767635)
55. S Nguyen N Dhedin J-P Vernant, et al. 2005 NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect Blood 105 4135 4142 15687235 10.1182/blood-2004-10-4113 1:CAS:528:DC%2BD2MXktlSrt7c%3D (Pubitemid 40656166)
56. R Pacasova S Martinozzi HJ Boulouis, et al. 1999 Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice J Immunol 162 5190 5196 10227992 1:CAS:528:DyaK1MXislGgur0%3D (Pubitemid 29307123)
57. F Paladini F Belfiore E Cocco, et al. 2009 HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia Arthritis Res Ther 11 R171 19912639 10.1186/ar2860
58. KS Park JH Park YW Song 2008 Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis Tissue Antigens 72 342 346 18700876 10.1111/j.1399-0039.2008.01110.x 1:CAS:528:DC%2BD1cXht1Gkt7fE
59. KS Park JS Park JH Nam, et al. 2007 HLA-E 0101 and HLA-G 010101 reduce the risk of Behcet's disease Tissue Antigens 69 139 144 17257316 10.1111/j.1399-0039.2006.00742.x 1:CAS:528:DC%2BD2sXjsVejtLo%3D (Pubitemid 46174868)
60. JJ Pérez-Villar M Carretero F Navarro, et al. 1996 Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor J Immunol 157 5367 5374 8955184 (Pubitemid 126448955)
61. G Pietra C Romagnani P Mazzarino, et al. 2003 HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8 + cytolytic T lymphocytes Proc Natl Acad Sci USA 100 10896 10901 12960383 10.1073/pnas. 1834449100 1:CAS:528:DC%2BD3sXnslyntLg%3D (Pubitemid 37140124)
62. B Plougastel J Trowsdale 1997 Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes Eur J Immunol 27 2835 2839 9394807 10.1002/eji.1830271114 1:CAS:528:DyaK2sXnt1OjsL8%3D (Pubitemid 27478351)
63. A Rodríguez M Carretero J Glienke, et al. 1998 Structure of the human CD94 C-type lectin gene Immunogenetics 47 305 309 9472066 10.1007/s002510050362 (Pubitemid 28105439)
64. C Romagnani G Pietra M Falco, et al. 2002 Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells Proc Natl Acad Sci USA 99 11328 11333 12167676 10.1073/pnas.172369799 1:CAS:528:DC%2BD38XmslSmuro%3D (Pubitemid 34920925)
65. R Salerno-Gonçalves M Fernandez-Viña DM Lewinsohn, et al. 2004 Identification of a human HLA-E-restricted CD8 + T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine J Immunol 173 5852 5862 15494539 (Pubitemid 39392176)
66. D Schulte M Vogel B Langhans, et al. 2009 The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells J Infect Dis 200 1397 1401 19780673 10.1086/605889 1:CAS:528:DC%2BD1MXhsVOltL%2FJ
67. J Seo JS Park JH Nam, et al. 2007 Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease Tissue Antigens 70 307 313 17767552 10.1111/j.1399-0039.2007.00907.x 1:CAS:528:DC%2BD2sXhtFKns7%2FO (Pubitemid 47340735)
68. SM Shawar JM Vyas JR Rodgers, et al. 1994 Antigen presentation by major histocompatibility complex class I-B molecules Annu Rev Immunol 12 839 880 8011299 10.1146/annurev.iy.12.040194.004203 1:CAS:528:DyaK2cXivFKisr0%3D (Pubitemid 24140433)
69. Y Sobanov J Glienke C Brostjan, et al. 1999 Linkage of the NKG2 and CD94 receptor genes to D12S77 in the human natural killer gene complex Immunogenetics 49 99 105 9887346 10.1007/s002510050468 1:CAS:528:DyaK1MXhtVOktbo%3D (Pubitemid 29037597)
70. R Steffensen OB Christiansen EP Bennett, et al. 1998 HLA-E polymorphism in patients with recurrent spontaneous abortion Tissue Antigens 52 569 572 9894856 10.1111/j.1399-0039.1998.tb03088.x 1:CAS:528:DyaK1MXlt1ehsw%3D%3D (Pubitemid 29002761)
71. RK Strong MA Holmes P Li, et al. 2003 HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities J Biol Chem 278 5082 5090 12411439 10.1074/jbc.M208268200 1:CAS:528:DC%2BD3sXhtVKlt7o%3D (Pubitemid 36801018)
72. LC Sullivan CS Clements J Rossjohn, et al. 2008 The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity Tissue Antigens 72 415 424 18946929 10.1111/j.1399-0039.2008.01138.x 1:CAS:528:DC%2BD1cXhsVCmsbbP
73. R Tamouza M Busson C Fortier, et al. 2007 HLA-E 0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia Hum Immunol 68 849 853 17961774 10.1016/j.humimm.2007.08.260 1:CAS:528:DC%2BD2sXht1anu7fL (Pubitemid 47610697)
74. R Tamouza M Busson V Rocha, et al. 2006 Homozygous status for HLA-E 0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation Transplantation 82 1436 1440 17164714 10.1097/01.tp.0000244598.92049.dd 1:CAS:528:DC%2BD28XhtlSrsL7P (Pubitemid 44967625)
75. R Tamouza V Rocha M Busson, et al. 2005 Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation Transplantation 80 140 144 16003246 10.1097/01.TP.0000158711.37550.A0 1:CAS:528:DC%2BD2MXlvVylur0%3D (Pubitemid 40980908)
76. P Tomasec VM Braud C Rickards, et al. 2000 Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40 Science 287 1031 10669413 10.1126/science.287.5455.1031 1:CAS:528: DC%2BD3cXhtFyktrc%3D (Pubitemid 30094357)
77. P Tripathi S Agrawal 2007 The role of human leukocyte antigen E and G in HIV infection AIDS 21 1395 1404 17589185 10.1097/QAD.0b013e32810c8bbc (Pubitemid 46987999)
78. P Tripathi S Naik S Agrawal 2006 HLA-E and immunobiology of pregnancy Tissue Antigens 67 207 213 16573557 10.1111/j.1399-0039.2005.00550.x 1:CAS:528:DC%2BD28XksFCms78%3D (Pubitemid 43383368)
79. A Trundley A Moffett 2004 Human uterine leukocytes and pregnancy Tissue Antigens 63 1 12 14651517 10.1111/j.1399-0039.2004.00170.x 1:CAS:528: DC%2BD2cXhsVSnt7s%3D (Pubitemid 38130436)
80. M Ulbrecht S Modrow R Srivastava, et al. 1998 Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation J Immunol 160 4375 4385 9574542 1:CAS:528: DyaK1cXjtVCms74%3D (Pubitemid 28217295)
81. RE Vance AM Jamieson DH Raulet 1999 Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells J Exp Med 190 1801 1812 10601355 10.1084/jem.190.12.1801 1:CAS:528:DC%2BD3cXitleq (Pubitemid 30013846)
82. C Watzl EO Long 2003 Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts J Exp Med 197 77 85 12515815 10.1084/jem.20020427 1:CAS:528:DC%2BD3sXjslWlsw%3D%3D (Pubitemid 36110259)
83. J Wischhusen MA Friese M Mittelbronn, et al. 2005 HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo J Neuropathol Exp Neurol 64 523 528 15977644 1:CAS:528: DC%2BD2MXlvVSgtro%3D (Pubitemid 40781155)
84. SL Wooden SR Kalb RJ Cotter, et al. 2005 Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis J Immunol 175 1383 1387 16034073 1:CAS:528:DC%2BD2MXmtlWjsbk%3D (Pubitemid 41023037)
85. J Wu Y Song AB Bakker, et al. 1999 An activating immunoreceptor complex formed by NKG2D and DAP10 Science 285 730 732 10426994 10.1126/science.285.5428. 730 1:CAS:528:DyaK1MXltVehsrc%3D (Pubitemid 29484540)